Principal Financial Group Inc Kala Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$1.16 - $2.74 $14,187 - $33,512	-12,231 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.62 - $5.43 $5,184 - $10,745	-1,979 Reduced 13.93%	12,231 $32,000
Q2 2021 Aug 10, 2021	BUY	$5.06 - $8.15 $8,895 - $14,327	1,758 Added 14.12%	14,210 $75,000
Q1 2021 May 10, 2021	SELL	$6.24 - $9.58 $60,565 - $92,983	-9,706 Reduced 43.8%	12,452 $84,000
Q4 2020 Feb 08, 2021	BUY	$6.28 - $8.79 $139,152 - $194,768	22,158 New	22,158 $150,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.